The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of KRAS mutation status on outcomes in peritoneal metastatic mucinous adenocarcinoma of the colon and appendix following CRS-HIPEC: A retrospective analysis.
 
Sanjana Mullangi
No Relationships to Disclose
 
Manidhar Reddy Lekkala
Stock and Other Ownership Interests - Abbvie; crispr therapeutics; Lilly; NeoGenomics Laboratories; Pfizer; Teva
 
Aubrey Swilling
No Relationships to Disclose
 
Jill Haley
No Relationships to Disclose
 
Weijing Sun
Honoraria - Astellas Pharma; Merck
Consulting or Advisory Role - AstraZeneca; Macrogenics
Research Funding - AstraZeneca (Inst); Merck (Inst); Novella Clinical (Inst)
 
Raed Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Joaquina Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Merus; Moderna Therapeutics; Novo Nordisk; Zymeworks
Research Funding - Astellas Pharma (Inst); Chungchun Intellicrown (Inst); Exelixis (Inst); Genentech/Roche (Inst); IMPAC Medical Systems (Inst); Merck (Inst); Poseida (Inst); Sanofi (Inst); Synermore (Inst); Xencor (Inst)
 
Haoran Li
No Relationships to Disclose
 
Luke Selby
Stock and Other Ownership Interests - Exact Sciences; Guardant Health; Immatics; Iovance Biotherapeutics
 
Shahid Umar
No Relationships to Disclose
 
Mazin Mazin Al-Kasspooles
No Relationships to Disclose
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)